A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)
Clinical trial NCT00959699 · COMPLETED
Trial details
- NCT number
- NCT00959699
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2012-05-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.